vimarsana.com

Latest Breaking News On - Shain gozani - Page 8 : vimarsana.com

NeuroMetrix strategically launches Quell Fibromyalgia

NeuroMetrix announced the strategic launch of its Quell Fibromyalgia device through its Pathfinder Program.

United-states
Shain-gozani
Pathfinder-program
Quell-fibromyalgia

NeuroMetrix Announces Strategic Launch of Quell Fibromyalgia

03.11.2022 - WOBURN, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) - NeuroMetrix, Inc. (Nasdaq: NURO) today announced the strategic launch of its Quell Fibromyalgia device through the Pathfinder Program. Quell Fibromyalgia is the first and only medical device .

Thomast-higgins
Shain-gozani
Pathfinder-program
Neurometrix-inc
Chief-executive-officer
Quell-fibromyalgia
Chief-financial

NeuroMetrix (NURO) Appoints Brad Fluegel to its Board

NeuroMetrix (NURO) Appoints Brad Fluegel to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Shain-gozani
Bradleym-fluegel
Reden-anders-optum
Walgreens
Elevance-health
Healthcare-commercial-market-development
Walgreen
Nasdaq
Boards-of-directors-performant-financial-corporation
University-of-washington

NeuroMetrix's Quell neuromodulation device wins FDA de novo nod to treat fibromyalgia

NeuroMetrix announced today that it received FDA de novo authorization for its Quell neuromodulation device, indicated to treat fibromyalgia.

Shain-gozani
Patient-global-impression
Fibromyalgia-impact-questionnaire

Wearable TENS Device Cleared for Fibromyalgia Treatment

The Quell neuromodulation device has received the FDA De Novo authorization for use as an aid in reducing the symptoms of fibromyalgia.

Shain-gozani
Drug-administration-de-novo
Patient-global-impression
Fibromyalgia-impact-questionnaire
Chief-executive-officer

vimarsana © 2020. All Rights Reserved.